Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical trial of SRK-439 for the treatment of obesity

Next Previous
Trial Profile

A clinical trial of SRK-439 for the treatment of obesity

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 24 Jun 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs SRK 439 (Primary)
  • Indications Obesity
  • Focus Adverse reactions; First in man

Most Recent Events

  • 18 Jun 2025 According to Scholar Rock media release, Company is on track to file an IND application for SRK-439 in the second half of this year to support the first in human study.
  • 27 Feb 2025 According to Scholar Rock media release, IND application for SRK-439 for the treatment of obesity in patients on standard of care GLP-1 RAs expected to be filed in 3Q 2025.
  • 19 Mar 2024 According to Scholar Rock media release, the company expected to commence this trial in mid-2024 with data expected in mid-2025.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top